Fact-checked by Grok 2 weeks ago

Leghemoglobin


Leghemoglobin is a heme-containing synthesized in the nodules of leguminous during symbiotic association with nitrogen-fixing .
It reversibly binds oxygen with high affinity, maintaining low free-oxygen levels to protect the oxygen-sensitive enzyme essential for converting atmospheric into , while permitting sufficient oxygen for bacteroid . Structurally analogous to animal , leghemoglobin imparts a characteristic pink or red hue to active nodules and exists in multiple isoforms tailored to specific species and environmental conditions. Its involves plant-encoded apoprotein combined with bacterially supplied , highlighting the interdependence in the . Beyond , recombinant soy leghemoglobin produced in via serves as a color and enhancer in plant-based products, replicating heme-mediated meat-like properties upon heating. Regulatory bodies including the FDA and EFSA have affirmed its safety for consumption based on toxicology studies showing no adverse effects at high doses, though initial approvals faced challenges from advocacy groups citing insufficient long-term data on genetically modified ingredients.

Discovery and Historical Context

Initial Identification and Early Research

Leghemoglobin was first identified in 1939 by Hiroyuki Kubo, researcher who extracted and analyzed the red pigment responsible for the pink coloration of root nodules in soybeans (Glycine max). Kubo demonstrated that this pigment was protein with spectral properties akin to hemoglobins, present in concentrations up to 5-7 millimolar in nodule extracts, far exceeding those in tissues. His involved crushing nodules and precipitating the protein, revealing its oxygen-binding capability through basic spectroscopic observations, though full purification was limited by wartime constraints. In 1945, David Keilin and Yew-Lan Wang advanced the characterization using partially purified extracts (approximately 50% purity) from root nodules of various leguminous plants, including soybeans and peas. They confirmed leghemoglobin's reversible oxygen-binding affinity via absorption spectroscopy, noting characteristic bands at 540 nm and 575 nm for the oxy-form, and its autoxidizability to metleghemoglobin, distinguishing it from myoglobin due to higher oxygen affinity (P50 around 0.04 mm Hg). This work established leghemoglobin as a plant-derived hemoglobin facilitating low free-oxygen diffusion in nodules, protecting oxygen-sensitive nitrogenase while supplying respiring bacteroids. Early post-war research in the late and focused on purification techniques and comparative studies across , with C.A. Appleby achieving crystalline forms from lupin nodules by 1957, enabling amino acid composition analysis and confirmation of multiple isoforms. These efforts revealed leghemoglobin's monomeric structure (about 16 kDa) and , initially speculated to be bacterially supplied but later traced to host plant synthesis through experiments in the . Such studies underscored its symbiosis-specific expression, absent in non-nodulated roots, laying groundwork for linking it to efficiency.

Integration into Nitrogen Fixation Studies

Leghemoglobin was first identified in 1939 by Japanese researcher Hisayoshi Kubo, who isolated a red pigment from soybean (Glycine max) root nodules and characterized it as a hemoglobin-like protein through spectroscopic and chemical analysis. This discovery integrated leghemoglobin into early investigations of symbiotic nitrogen fixation, as the pigment's presence correlated with the pink coloration of functional nodules housing Rhizobium bacteria capable of reducing atmospheric N₂. Prior observations had noted the absence of this color in ineffective or non-nitrogen-fixing nodules, prompting Kubo's work to link the protein directly to the symbiotic process. In the , biochemist Artturi Ilmari Virtanen and collaborators advanced this integration by quantifying leghemoglobin levels and demonstrating a direct proportionality between its concentration in nodules and rates of . Their 1947 studies on various , including peas and beans, showed that nodules with higher leghemoglobin content exhibited greater acetylene reduction activity—a for N₂ fixation—and that leghemoglobin depletion, induced experimentally, impaired fixation efficiency. Virtanen et al. proposed that leghemoglobin facilitates oxygen delivery to bacteroids for respiratory energy needs while mitigating oxygen's inhibitory effects on , the enzyme complex catalyzing N₂ reduction. These findings, building on Kubo's identification, established leghemoglobin as a key biochemical marker and potential regulator in symbiotic models, influencing field and lab assays for fixation capacity. Subsequent research from the 1960s onward incorporated leghemoglobin into mechanistic studies of the "oxygen paradox" in , where bacteroids require O₂ for ATP production but demands microaerobic conditions. In 1974, experiments with isolated bacteroids confirmed leghemoglobin's role in facilitated O₂ , enhancing respiratory rates by up to 40-fold compared to diffusion alone, thus supporting sustained activity. and spectrophotometric assays further quantified how leghemoglobin's high-affinity O₂ binding (with P₅₀ values around 10–40 nM) maintains nodule O₂ at 10–20 nM, optimal for fixation. Genetic approaches in the 2000s provided causal evidence, with knockdown of leghemoglobin genes in reducing nodule leghemoglobin by over 80%, abolishing , and causing nodule , while plant growth remained viable under mineral nitrogen fertilization. This 2005 study resolved prior correlative debates, confirming leghemoglobin's necessity for symbiotic without broader developmental roles. Ongoing integration includes transcriptomic analyses linking leghemoglobin expression to nodule-specific transcription factors like NIN-like proteins, which regulate its synthesis in response to rhizobial signals. These advancements have refined models of , emphasizing leghemoglobin's centrality in empirical assays and efforts for enhanced fixation.

Biochemical Structure and Properties

Molecular Composition and Heme Interaction

Leghemoglobin is a monomeric protein composed of a single polypeptide chain typically comprising 140-150 , resulting in an apoprotein of approximately 16-17 kDa. The is a single protoheme IX , containing a iron (Fe²⁺) atom that enables reversible oxygen binding. This is non-covalently attached within a hydrophobic pocket formed by the folded , exhibiting tight binding that resists dissociation under physiological conditions due to hydrophobic interactions and coordination bonds. Sequence variants across species, such as leghemoglobin a, show to animal myoglobins but with distinct primary structures, including an acidic contributing to the protein's in nodule . The iron is axially coordinated by the side chain of a proximal residue, designated His F8 in standard helical numbering (e.g., His92 in leghemoglobin a), which forms a strong bond stabilizing the and facilitating during . On the distal side, the pocket features a at position E11 (Leu65 in some alignments) and a at B10, which modulate access and affinity; unlike myoglobin's distal , this configuration promotes high oxygen association rates while hindering auto-oxidation by limiting water entry. The overall structure adopts a classic fold with seven α-helices (A-C, E-H, lacking D) enveloping the , as resolved in structures at 2.2 Å for recombinant forms. In the deoxy form, the heme iron is pentacoordinate, with the fifth coordination site available for diatomic ligands like O₂ or , whose binding is further stabilized by hydrogen bonding from a distal (His E7, e.g., His61) to the ligand's terminal atom. This interaction, observed at distances of 2.64-3.08 Å in ligand complexes, enhances the protein's unusually high oxygen (P₅₀ ≈ 0.04 mmHg), optimized for maintaining low free oxygen levels in nodules. The pocket's flexibility accommodates larger exogenous ligands, such as or nicotinate, underscoring its structural adaptability while preserving core -globin interactions essential for function.

Oxygen Binding Characteristics and Variants

Leghemoglobin displays exceptionally high , with a P50 value of approximately 0.04 , enabling tight binding at the low oxygen concentrations prevalent in root nodules. This arises from a very high oxygen association rate constant (around 250 μM⁻¹ s⁻¹) combined with a moderately high dissociation rate, resulting in kinetics optimized for maintaining microaerobic conditions that protect while facilitating respiration. 00268-X) The iron in leghemoglobin remains pentacoordinate during oxygen binding, lacking the hexacoordination seen in class 1 hemoglobins, which enhances reactivity toward O₂ and contributes to the rapid on-rate. These properties yield oxygen binding affinities 11 to 24 times higher than those of , underscoring leghemoglobin's role in buffering free oxygen flux. Multiple isoforms of leghemoglobin occur within individual species, often encoded by distinct genes and exhibiting subtle variations in sequence that influence binding parameters. In (Glycine max), for instance, major isoforms include Lba, Lbb, and , which differ in expression patterns across nodule development and may possess minor differences in oxygen affinity or stability to adapt to fluctuating nodule microenvironments. These variants generally retain the core high-affinity profile of leghemoglobin but allow species-specific tuning, such as through altered association or dissociation kinetics, to optimize symbiotic efficiency under varying oxygen or stress conditions. Such isoform diversity, evolved from class 2 ancestors, supports compartmentalized oxygen management without compromising the overall low free-oxygen threshold essential for .

Physiological Functions in Plants

Role in Symbiotic Nitrogen Fixation

Leghemoglobin, synthesized in the infected cells of legume root nodules, facilitates symbiotic nitrogen fixation by maintaining microaerobic conditions essential for the activity of the oxygen-sensitive nitrogenase enzyme in rhizobial bacteroids. Nitrogenase catalyzes the reduction of atmospheric dinitrogen (N₂) to ammonia, a process requiring substantial ATP generated via bacteroid respiration, which paradoxically demands oxygen as a terminal electron acceptor. Leghemoglobin binds oxygen reversibly with high affinity, buffering free oxygen concentrations at low levels (approximately 10-30 nM in active nodules) to prevent nitrogenase inactivation while enabling adequate oxygen flux for respiration. This dual function—oxygen transport and protection—addresses the oxygen paradox in nodules: high total oxygen content via leghemoglobin-saturated forms supports energy demands, yet dissolved free oxygen remains low enough to safeguard . Experimental evidence from isolated bacteroids demonstrates that exogenous oxy-leghemoglobin enhances oxygen uptake and activity, confirming its role in across the nodule's variable permeability barrier. Genetic studies in model legumes like show that knockout of multiple leghemoglobin genes results in elevated free oxygen, instability, overproduction, and near-complete abolition of , underscoring its indispensability. Leghemoglobin's expression is tightly regulated, peaking in the fixation zone of mature nodules where symbiotic activity is highest, with symbiotic leghemoglobins acting synergistically to optimize fixation rates. The pink coloration of functional nodules, derived from leghemoglobin, serves as a visual indicator of active , absent in ineffective or mutant nodules. Disruptions such as or chilling can impair leghemoglobin stability, reducing fixation efficiency by altering oxygen diffusion barriers or increasing .

Evidence and Debate on Primary Mechanisms

Leghemoglobin primarily functions to oxygen concentrations within nodules, maintaining free oxygen levels at approximately 10-20 nM to protect the oxygen-labile while facilitating oxygen delivery for bacteroid . This dual role addresses the "oxygen paradox" in symbiotic , where requires microaerobic conditions for activity, yet ATP production via demands oxygen. Biophysical models demonstrate that leghemoglobin's high oxygen affinity and rapid association kinetics enable , increasing effective oxygen uptake by bacteroids up to 40-fold compared to free alone. Genetic evidence from and / knockouts in species like confirms leghemoglobin's indispensability for symbiotic . In leghemoglobin-deficient nodules, free oxygen rises dramatically, leading to nitrogenase inactivation, reduced acetylene reduction rates by over 90%, and nodule . Multiple leghemoglobin isoforms exhibit synergistic effects, with single-gene knockouts causing partial fixation and combinatorial disruptions abolishing activity entirely, underscoring their non-redundant contributions to oxygen . Spectroscopic and microelectrode measurements in intact nodules corroborate these findings, showing leghemoglobin-saturated states correlate directly with nitrogenase-linked and ATP supply. Debate on leghemoglobin's mechanisms has largely centered on the relative primacy of oxygen buffering versus , with early physiological studies suggesting passive scavenging predominates, while kinetic analyses emphasize as the key enhancer of respiratory efficiency. Some researchers propose ancillary roles, such as via heme-nitrosyl complexes, but empirical data indicate these are secondary, as oxygen regulation alone accounts for the observed fixation deficits in mutants. No evidence supports leghemoglobin as dispensable for fixation under alternative nodule oxygenation strategies, as barriers and bacteroid adaptations fail to compensate in its absence. Ongoing studies explore isoform-specific affinities, but consensus affirms oxygen management as the causal core of its physiological impact.

Variations Across Legume Species

Leghemoglobin (Lb) genes and proteins display significant diversity across species, including differences in gene copy number, isoform multiplicity, sequences, oxygen-binding affinities, and spatial expression patterns within nodules. This variation likely reflects evolutionary adaptations to distinct symbiotic partners and environmental conditions, though direct causal links remain under investigation. For instance, (Glycine max) nodules contain up to eight detectable isoleghemoglobins (isoLbs), the highest reported multiplicity among studied , enabling fine-tuned oxygen management during . In contrast, (Pisum sativum) exhibits five isoLbs, with two major gene types (Lb^a and Lb^c) showing distinct oxygen association rates—Lb^a with a high-affinity form (approximately 0.018 μM⁻¹ s⁻¹) suited for central nodule zones, and Lb^c with lower affinity (approximately 0.009 μM⁻¹ s⁻¹) predominant in infected cells near . Alfalfa ( sativa) features two distinct groups of Lb genes, differing from in regulatory mechanisms and potentially in promoter responsiveness to symbiotic signals, highlighting interspecies divergence in organization despite shared ancestry. Similarly, the model legume possesses three symbiotic Lb genes, which collectively maintain low free oxygen levels essential for rhizobial activity, as demonstrated by RNAi knockdown experiments reducing Lb synthesis and elevating nodule oxygen to inhibitory levels (above 20 nM). In the genus, encompassing species like common (P. vulgaris), Lb profiles vary intraspecifically and interspecifically, with electrophoretic analyses revealing polymorphic banding patterns transferable via hybridization, suggesting utility for programs aimed at enhancing symbiotic . Sequence-level differences further underscore this heterogeneity; pea Lb isoforms diverge by up to 20% in identity, influencing pocket stability and ligand kinetics, while broader phylogenetic analyses across indicate Lb expansions tied to nodulation diversification post-whole-genome duplications. These variations do not uniformly correlate with nodule or host-rhizobia specificity, as evidenced by comparable Lb complement in determinate (e.g., ) versus indeterminate (e.g., ) nodule types, implying functional redundancy tempered by species-specific selective pressures. Empirical gaps persist in linking specific sequence motifs to physiological outcomes across understudied tropical , where fewer genomic resources limit comparative insights.

Non-Symbiotic and Other Plant Hemoglobins

Non-symbiotic hemoglobins (nsHbs), also referred to as phytoglobins, constitute a diverse group of oxygen-binding proteins present in all land plants, , and some , functioning independently of symbiotic . Unlike leghemoglobins, which are specialized for oxygen delivery in nodules, nsHbs exhibit hexacoordination of the iron by a distal , resulting in higher oxygen affinity (dissociation constants typically 1-10 nM) and distinct ligand binding kinetics. These proteins are monomeric or dimeric, with molecular masses around 18-25 kDa per subunit, and their expression is regulated by environmental cues such as , rather than nodule development. nsHbs are phylogenetically divided into three classes: class 1, class 2, and truncated (class 3). Class 1 nsHbs, the most studied, are rapidly upregulated under low-oxygen conditions via hypoxia-responsive promoters, facilitating (NO) dioxygenation to , which mitigates NO-mediated inhibition of mitochondrial and restores ATP . For instance, in , class 1 nsHb1 (AHb1) overexpression enhances tolerance to flooding by maintaining balance and status. Class 2 nsHbs, expressed constitutively at lower levels, display lower oxygen affinity and may participate in alternative roles, such as hormone signaling or pathogen response, though their precise mechanisms remain under investigation. Truncated nsHbs lack the N- and C-terminal extensions of full-length forms, feature a shorter for ligand access, and are implicated in rapid gas diffusion under , with examples in showing induction during . Beyond response, nsHbs influence developmental processes and adaptation. In and , class 1 nsHbs modulate root architecture and , with spinach SoHb upregulated by excess to prevent nitrosative damage. They also contribute to , flowering, and by scavenging , as evidenced by reduced sizes in nsHb-expressing plants during hypersensitive responses. In non-legume like and , nsHbs support submergence tolerance, with studies revealing heightened sensitivity to due to impaired energy . While early models emphasized NO , recent suggests broader signaling roles, including interactions with phytohormones like and , though causal links require further empirical validation through targeted mutants. In , nsHbs coexist with leghemoglobins but localize to non-nodulated tissues, such as or hypoxic zones outside , potentially buffering oxygen fluctuations during nodule maturation. Crystal structures, such as that of class 1 nsHb (PDB: 4C0N), reveal a compact pocket with a Tyr-B10 residue stabilizing ligands, contrasting the open pocket of leghemoglobins and enabling hexacoordinate resting states. rates vary by class, with class 1 nsHbs showing faster ferric transitions under normoxia, necessitating controls via ferritins or ascorbate. These properties underscore nsHbs' evolutionary adaptation for versatile, non-symbiotic gas chemistry in diverse lineages.

Commercial Production and Applications

Recombinant Engineering and Fermentation Methods

Recombinant production of leghemoglobin (LegH) primarily involves inserting the coding sequence for LegH, such as the Lgb3 or LGB2 gene, into yeast expression systems to enable scalable synthesis of the functional holo-protein, which requires both the apoprotein and cofactor. Pichia pastoris (reclassified as Komagataella phaffii) serves as the predominant host due to its capacity for high-density fermentation and methanol-inducible promoters like AOX1, which drive strong expression. Engineering strategies include signal peptides (e.g., alpha-factor or native LegH signals) for secretory expression to simplify downstream purification, multi-copy gene integration for dosage optimization, and co-expression or overexpression of genes (e.g., HEM1-HEM15 pathway enzymes) to mitigate bottlenecks in cofactor assembly, as apo-LegH yields alone do not produce the oxygen-binding active form. These modifications have achieved secretory titers exceeding 1 g/L in optimized strains, with functionality verified by confirming incorporation and oxygen affinity similar to native plant-derived LegH. Alternative hosts like and have been explored, yielding up to 88.5 mg/L via constitutive promoters and oxygen-sensing regulation tweaks, though they generally underperform P. pastoris in -coupled production. Fermentation protocols emphasize fed-batch processes to sustain high cell densities (up to 200 g/L dry weight) while controlling oxygen levels, as LegH's role in oxygen stabilization necessitates aerobic conditions without toxicity. For P. pastoris, cultivation begins with glycerol-based growth media (e.g., BMGY or BSM) for biomass accumulation, followed by methanol induction to activate AOX1-driven expression, with feeds adjusted via dissolved oxygen feedback to prevent repression or oxidative stress. Media variations like FM22 or D'Anjou formulations influence yields, with buffered systems (pH 5-6) and trace metal supplementation enhancing heme flux; for instance, glycerol-methanol mixtures optimized via metabolic modeling increased LegH output by coupling growth to biosynthesis. Commercial-scale production, as in Impossible Foods' GRAS-approved process (GRN 000737, 2018), uses submerged fed-batch fermentation of recombinant P. pastoris on plant-derived sugars, yielding a LegH preparation concentrated post-harvest via filtration and ultrafiltration, with purity exceeding 90% heme-bound protein. Purification steps include ion-exchange chromatography and heat treatment to remove impurities, ensuring the final product mimics native LegH's pink pigmentation and stability under food processing conditions. Recent advancements, including CRISPR-mediated pathway edits, have further boosted efficiency, as seen in EU EFSA-evaluated strains (2024) producing LegH at industrially viable levels without residual genetic material from the host.

Integration into Plant-Based Food Products

Soy leghemoglobin (LegH), produced recombinantly in genetically engineered yeast such as Pichia pastoris, is integrated into plant-based meat analogs primarily to replicate the sensory and nutritional attributes of animal-derived . In products like the Impossible Burger, LegH is incorporated at concentrations of approximately 0.8% by weight during formulation, where it binds to form a stable complex that imparts a raw meat-like pink hue and enables a "bleeding" effect upon cutting, mimicking fresh . Upon cooking, the protein denatures, releasing which participates in Maillard reactions and oxidation, generating savory, flavors characteristic of browned meat, including notes of roasted and blood-like aroma. This enhances the overall and juiciness of plant-based patties by stabilizing and contributing to gelation properties during , allowing for or forming techniques that yield textured, cohesive products without animal proteins. LegH also serves as a bioavailable iron source, with each gram providing about 2.5 mg of iron, comparable to , thereby addressing nutritional gaps in vegan alternatives. Commercial adoption began with in 2016, scaling to millions of units sold annually by 2019, though it remains concentrated in their burger and sausage products rather than widespread across the . Emerging applications include potential use in other heme-fortified analogs, such as those from genetically modified Komagataella phaffii strains, but as of , no major competitors have commercialized LegH at scale due to production costs and proprietary formulations. Challenges in integration include optimizing LegH stability in plant protein matrices, which can vary by base ingredients like soy or , requiring adjustments (around 6.0-7.0) and heme loading ratios to prevent off-colors or bitterness from unbound iron. Sensory panels have confirmed that LegH addition improves blind taste tests against by 20-30% in authenticity scores, though excess levels (>1%) can introduce metallic notes. Regulatory frameworks, such as FDA approval for use as a color additive up to 0.8% in analogs on July 31, , have facilitated market entry, but integration remains limited to approved formulations to ensure compliance with labeling for soy-derived components.

Regulatory Approvals and Market Adoption

Soy leghemoglobin, produced recombinantly for use in plant-based meat analogs, received Generally Recognized as Safe (GRAS) status from the U.S. Food and Drug Administration (FDA) via GRAS Notice No. 737 in July 2018, permitting its use at up to 0.8% in ground beef analogue products intended for cooking. The FDA concluded that the ingredient, derived from genetically modified yeast fermentation, posed no safety concerns under intended conditions based on submitted toxicology and allergenicity data. In July 2019, the FDA approved a color additive petition for soy leghemoglobin, enabling its broader application in plant-based foods for mimicking meat's red color and flavor, with a final rule effective December 2019 listing it as exempt from certification. This approval followed scrutiny of production processes and safety studies, though critics, including the Center for Food Safety, challenged it in court over alleged inadequate long-term testing; the Ninth Circuit Court of Appeals upheld the FDA's decision in May 2021, affirming reliance on available empirical data. Internationally, Health Canada issued a letter of no objection in May 2021 for soy leghemoglobin as a novel food ingredient in simulated meat products, aligning with U.S. safety findings after reviewing compositional, nutritional, and toxicological data. Approvals followed in Singapore, Hong Kong, and Macau, with Food Standards Australia New Zealand granting permission in December 2020 for use in meat analogues via Application A1186, based on assessments of no significant health risks. In the European Union, the European Food Safety Authority (EFSA) issued a positive opinion in November 2024 on the genetically modified yeast-derived soy leghemoglobin for use in meat substitutes, deeming it safe for human consumption pending final regulatory authorization, though public comments highlighted gaps in long-term exposure data. The Norwegian Scientific Committee for Food and Environment concurred with EFSA's risk assessment in February 2025, supporting import and processing approvals under EU Regulation 1829/2003. Market adoption has centered on ' products, with soy leghemoglobin enabling the Impossible Burger's commercialization since 2016 in the U.S., expanding to retail and foodservice by 2019 post-FDA color approval, contributing to North America's leading share in the global soy leghemoglobin market. By 2021, the ingredient supported exports to and select Asian markets, with projections estimating the market's value rising from USD 311 million in 2025 to USD 844 million by 2035 at a driven by demand for realistic plant-based meats. Adoption remains limited outside Impossible's portfolio, with no widespread use in other brands as of 2025, reflecting regulatory hurdles and reliance on for cost-effective production.

Safety Assessments and Criticisms

Toxicology and Allergenicity Data

Soy leghemoglobin (LegH) has been subjected to assessments primarily through repeated-dose oral studies in . In 28-day dietary toxicity studies conducted in Sprague-Dawley rats at doses up to 1,460 mg/kg body weight per day, no treatment-related adverse effects on clinical observations, body weights, food consumption, , , organ weights, or were observed, establishing a (NOAEL) of 750 mg/kg/day. This NOAEL exceeds estimated human intake by over 100-fold, based on the 90th percentile daily consumption of 3.5 mg/kg/day from products containing up to 0.8% LegH preparation. Similar studies evaluating female reproductive endpoints, including estrus cycling, hormone levels, and uterine/ovarian , reported no adverse effects. evaluations, including bacterial reverse mutation assays and mammalian chromosomal aberration tests, demonstrated that LegH preparation is non-mutagenic and non-clastogenic. Allergenicity assessments of LegH, produced via in Pichia pastoris or Komagataella phaffii, employed a weight-of-evidence approach incorporating bioinformatics, digestibility, and serum testing. Sequence alignments revealed no significant matches (less than 35% identity over 80 ) to known allergens in databases like WHO/FAO or AllergenOnline. pepsin digestion assays showed LegH degrades rapidly under simulated gastric conditions, comparable to common dietary proteins, reducing potential for intact protein absorption. Targeted serum IgE testing using pools from soy- or -allergic individuals yielded negative results, indicating no . While soy-derived, the purified LegH preparation contains minimal residual (below 0.01%), and Pichia-derived proteins pose no allergenicity risk even for those with yeast allergies, per FDA evaluations. These supported FDA's 2018 GRAS no-questions letter and 2019 color additive exemption, alongside EFSA's 2024 conclusion of no or allergenicity concerns for human consumption.

Key Concerns and Empirical Gaps

Despite regulatory approvals such as the U.S. FDA's no-questions letter on its GRAS status in 2018, criticisms have focused on the adequacy of safety testing for recombinant soy (LegH) used as a precursor in plant-based meats, including the exclusion of endpoints like and chronic exposure in FDA reviews. Advocacy groups like the Center for Science in the Public Interest argued that the FDA's evaluation overlooked cancer risk assessments associated with compounds, relying instead on short-term studies without multi-generational or carcinogenicity data. Similarly, the Center for highlighted potential allergenicity risks from soy-derived proteins, noting that while LegH itself shows low to known allergens, the GMO production process in could introduce trace contaminants or novel epitopes not fully characterized in human populations. Toxicological concerns center on heme's potential to catalyze oxidative reactions or form nitrosylated compounds under cooking conditions, though report no adverse effects at intakes exceeding exposure levels by over 100-fold, with a NOAEL of 750 mg/kg/day in 28-day trials. However, these findings derive primarily from industry-sponsored , raising questions about , and do not address interactions with other plant-based components that might amplify bioactivity. Allergenicity assessments indicate low risk, with no IgE or tests against soy allergens, but empirical challenge data remain absent, particularly for sensitized individuals. Key empirical gaps include the absence of long-term feeding studies in or to evaluate effects like or heme-mediated colorectal risks, as noted in reviews of plant-based analogs. Unlike native in animal products with millennia of consumption , recombinant LegH lacks intergenerational safety , and production in genetically modified Komagataella phaffii (formerly Pichia pastoris) introduces uncertainties around residual proteins or synthesis byproducts not replicated in natural nodules. panels in 2024 affirmed no but acknowledged limited on subchronic exposure and compositional variability across batches. Human epidemiological are nonexistent, with reliance on projected intakes rather than post-market surveillance, potentially underestimating rare adverse events in diverse populations.

Recent Scientific Advances

Innovations in Production Techniques (2023–2025)

Between 2023 and 2025, recombinant production of leghemoglobin advanced through targeted of microbial hosts, particularly yeasts, to boost expression yields and heme incorporation efficiency. In Kluyveromyces marxianus, researchers overexpressed genes in the heme biosynthesis pathway (e.g., HEM1, HEM2, HEM3, HEM12, HEM13, HEM15), achieving up to a 4.5-fold increase in intracellular levels and enabling leghemoglobin titers of approximately 1.2 g/L in optimized fed-batch , surpassing prior Pichia pastoris benchmarks. This approach addressed bottlenecks in assembly, a common limitation in . Parallel innovations in emphasized secretory expression via optimization and two-stage fed-batch strategies. A mutated α-factor facilitated extracellular secretion, yielding 544.8 mg/L leghemoglobin after depletion followed by , with per-unit productivity of 5.2 mg/L per OD600. In Komagataella phaffii (formerly pastoris), evaluations of media like BSM, BMGY, FM22, and revealed variable purification efficiencies but underscored the need for strain-specific tailoring, as standard optimizations failed to elevate yields beyond 200-300 mg/L in some setups. Regulatory assessments of engineered K. phaffii strains, such as MXY0541 expressing soy leghemoglobin LGB2, confirmed compositional equivalence to native forms while enabling scalable fermentation. Emerging cell-free systems offered rapid prototyping alternatives, with Escherichia coli-based extracts producing functional leghemoglobins and non-symbiotic hemoglobins at milligram scales per reaction, bypassing cellular toxicity from accumulation. Comparative secretory trials in S. cerevisiae and K. phaffii demonstrated higher folding fidelity for plant globins in the latter, though both achieved micromolar -bound outputs suitable for catalytic screening. A 2025 review highlighted metabolic flux balancing—via CRISPR-mediated promoter tuning and cofactor supplementation—as key to sustaining high-density fermentations across hosts, with titers approaching 2 g/L in select engineered lines. These developments prioritized empirical metrics over unverified scaling assumptions, revealing host-dependent trade-offs in and stability.

Emerging Biotechnological and Catalytic Uses

In recent advancements, engineered variants of soy leghemoglobin have been repurposed as biocatalysts for transfer reactions, marking the first application of the protein as a standalone outside its natural oxygen-binding function. A semi-rational design incorporating a K65P in the enabled efficient asymmetric N-H insertion of ethyl α-diazoacetate into , yielding 92% product with >99% enantiomeric excess, a (TON) of approximately 184, and a (TOF) of 15.3 h⁻¹. This variant exhibited over 1.6-fold higher initial reaction rates and improved thermostability compared to wild-type leghemoglobin, outperforming it in C-N bond formation for chiral synthesis while rivaling engineered and catalysts in heme protein biocatalysis. Published in October 2025 by Zhang et al., these modifications exploit conformational flexibility in the distal pocket to enhance binding and selectivity, opening avenues for sustainable of pharmaceuticals and fine chemicals. Beyond catalysis, leghemoglobin's moiety supports emerging biotechnological roles in iron fortification for plant-based nutrition, where its bioavailability rivals animal-derived . In cell assays, recombinant soy leghemoglobin demonstrated a relative of 27 ± 6% for iron uptake, statistically comparable to bovine (33 ± 10%) and superior to non-heme . This positions engineered leghemoglobin, produced via in hosts like Pichia pastoris, as a functional to address in vegetarian diets without relying on synthetic supplements, leveraging its GRAS status affirmed by the FDA in 2021. In , leghemoglobin variants are integrated into cell-free systems to facilitate heme-dependent biotransformations, such as generating flavor precursors from , nucleotides, and sugars via peroxidase-like activity of the prosthetic . These platforms enable of oxygen-sensitive reactions, drawing on leghemoglobin's native role in stabilizing low free-oxygen environments during . Ongoing efforts, including biosynthesis optimization in microbial hosts, further enhance yields for non-food applications like biosensors and oxygen delivery in engineered cellular consortia.

References

  1. [1]
    Expressed Soybean Leghemoglobin: Effect on Escherichia coli at ...
    Leghemoglobin (Lb) is an oxygen-binding plant hemoglobin of legume nodules, which participates in the symbiotic nitrogen fixation process.
  2. [2]
    Nitrogen Fixation by Legumes | New Mexico State University
    The pink or red color is caused by leghemoglobin (similar to hemoglobin in blood) that controls oxygen flow to the bacteria (Figure 2).
  3. [3]
    Wheat, Sorghum and Forage Research - Publication : USDA ARS
    Mar 3, 2020 · The 3/3 Glbs contain 2 kinds of structures, the first, leghemoglobin, is related to the animal myoglobin and functions in transporting ...
  4. [4]
    Secretory Production of Plant Heme-Containing Globins by ... - NIH
    Apr 20, 2025 · Leghemoglobin (LegHb) is a plant-derived heme-containing globin found in the root nodules of legumes like soybean that can be used as a food ...
  5. [5]
    [PDF] GRAS Notice No. GRN 000737; FDA has no questions
    Jul 23, 2018 · In Impossible Foods' notice, soy leghemoglobin preparation is described as red/brown.
  6. [6]
    Safety of soy leghemoglobin from genetically modified ... - NIH
    Jun 28, 2024 · After a safety evaluation conducted in 2020, Singapore Food Agency (SFA) considered soy leghemoglobin to be safe and authorised its use in meat ...
  7. [7]
    Plant hemoglobins: What we know six decades after their discovery
    Aug 15, 2007 · The discovery of plant Hbs. Plant Hbs were first identified by Kubo (1939). This author analyzed the red pigment of soybean root nodules ...
  8. [8]
    [PDF] Structure and function of leghemoglobins* - Digital CSIC
    Leghemoglobin (Lb) is a myoglobin-like protein of about 16 kDa, which occurs in legume root nodules at very high concentra - tions. Usually the heme moiety is ...
  9. [9]
    Hemoglobins in the legume–Rhizobium symbiosis - Larrainzar - 2020
    May 22, 2020 · The first plant hemoglobin was identified in 1939 by Kubo in soybean (Glycine max) nodules. This was followed by the demonstration by Keilin ...
  10. [10]
    The Kinetics of the Reactions of Leghemoglobin with Oxygen and ...
    Leghemoglobin a and leghemoglobin c, which differ in amino acid sequence and ... Keilin D. Wang Y.L.. Nature. 1945; 155: 227. Scopus (19) · Crossref · Google ...
  11. [11]
    Quantitative Estimation of Leghemoglobin Content in Legume Root ...
    Dec 4, 2020 · The oxygen-binding hemoprotein was first recognized in root nodules by Kubo in 1939. Leghemoglobin (Lb) occurs in the infected cells of legume ...Missing: early | Show results with:early<|separator|>
  12. [12]
    Plant hemoglobins: what we know six decades after their discovery
    Aug 15, 2007 · Plant Hbs were first identified in soybean root nodules, are known as leghemoglobins (Lbs) and have been characterized in detail.Missing: initial early
  13. [13]
    Quantitative Estimation of Leghemoglobin Content in Legume Root ...
    The oxygen-binding hemoprotein was first recognized in root nodules by Kubo in 1939. Leghemoglobin (Lb) occurs in the infected cells of legume root nodules.Missing: early | Show results with:early
  14. [14]
    Plant hemoglobins: Important players at the crossroads between ...
    Oct 25, 2011 · LegHb was the first plant hemoglobin discovered. It was described by Kubo [43] in 1939 and for a half of century remained the only known plant ...
  15. [15]
    On the relation between nitrogen fixation and leghaemoglobin ...
    On the relation between nitrogen fixation and leghaemoglobin content of leguminous root nodules.
  16. [16]
    Nitrogen Fixation and Leghemoglobin Content during Vegetative ...
    Virtanen et al., 1947. A.I. Virtanen, J. Jorma, H. Linkola, A. Linnasalmi. On the relation between nitrogen fixation and leghaemoglobin content of leguminous ...
  17. [17]
    A Functional Relationship Between Leghaemoglobin and ... - jstor
    Virtanen AI, Jorman J, Linkola H, Linnasalmi A. 1947. On the relation between nitrogen fixation and leghemoglobin content of leg- uminous root nodules. Acta ...
  18. [18]
    Intracellular site of synthesis and localization of leghemoglobin in ...
    1). In order to understand the physiological role of Lb in sym- biotic nitrogen fixation, we attempted to localize it at subcellular.<|control11|><|separator|>
  19. [19]
    Symbiotic leghemoglobins are crucial for nitrogen fixation in legume ...
    Mar 29, 2005 · Leghemoglobins accumulate to millimolar concentrations in the cytoplasm of infected plant cells prior to nitrogen fixation and are thought to ...
  20. [20]
    Symbiotic Leghemoglobins Are Crucial for Nitrogen Fixation in ...
    In summary, we have shown that the most prominent of legume nodulins, the leghemoglobins, are required for SNF, but not for plant growth and development in the ...
  21. [21]
    NIN-like protein transcription factors regulate leghemoglobin genes ...
    Oct 28, 2021 · Leghemoglobins enable the endosymbiotic fixation of molecular nitrogen (N2) in legume nodules by channeling O2 for bacterial respiration ...
  22. [22]
    Celebrating 20 Years of Genetic Discoveries in Legume Nodulation ...
    Since 1999, various forward- and reverse-genetic approaches have uncovered nearly 200 genes required for symbiotic nitrogen fixation (SNF) in legumes.
  23. [23]
    None
    ### Molecular Composition of Soybean Leghemoglobin a
  24. [24]
    Leghemoglobin - an overview | ScienceDirect Topics
    Leghemoglobins are nitrogen and oxygen carriers that are involved in the symbiosis between plants and nitrogen-fixating soil bacteria associated with plant ...
  25. [25]
    The amino-acid sequence of leghemoglobin component a ... - PubMed
    The complete amino acid sequence of kidney bean leghemoglobin a is compared to that of leghemoglobin a from soybean (Glycine max) and to some animal globins.Missing: heme | Show results with:heme
  26. [26]
    [PDF] Tyrosine B10 Inhibits Stabilization of Bound Carbon Monoxide and ...
    May 12, 2004 · The proximal pocket of leghemoglobin is designed to favor strong coordination bonds between the heme iron and axial ligands. Thus, high oxygen ...
  27. [27]
    correlations between oxygen affinity and sequence classifications of ...
    The leghemoglobins evolved from the Class 2 globins and show no hexacoordination, very high rates of O(2) binding ( approximately 250 muM(-1) s(-1)), moderately ...Missing: characteristics | Show results with:characteristics
  28. [28]
    Leghemoglobin - an overview | ScienceDirect Topics
    In plants leghemoglobins were first identified in nodules of legumes, where they transport oxygen to nitrogen-fixing endosymbiotic bacteria [1]. Additional ...
  29. [29]
    Leghemoglobin - an overview | ScienceDirect Topics
    Nitrogen fixation in land plants takes place through a symbiotic relationship between the plants and certain bacteria. Because legumes were among the first ...Missing: history | Show results with:history
  30. [30]
    Cell-Free Production of Soybean Leghemoglobins and ... - NIH
    Aug 12, 2025 · nsHb Class 1 proteins have very high affinity for O2 and are found in monocotyledons and legumes. LegH has attracted great interest in the ...
  31. [31]
    Facilitated oxygen diffusion. The role of leghemoglobin in nitrogen ...
    Facilitated oxygen diffusion. The role of leghemoglobin in nitrogen fixation by bacteroids isolated from soybean root nodules.Missing: barrier | Show results with:barrier
  32. [32]
    Alfalfa leghemoglobins: Structure & expression
    The function of leghemoglobin is to carry an ample supply of oxygen to the endosymbionts within the microaerobic environment of the root nodule so that nitrogen ...
  33. [33]
    CRISPR/Cas9 knockout of leghemoglobin genes in Lotus japonicus ...
    Complementation studies revealed that Lbs function synergistically to maintain optimal N2 fixation. The nodules of the triple mutants overproduced superoxide ...
  34. [34]
    The potential for the use of leghemoglobin and plant ferritin as ...
    Studies using ion exchange chromatography have shown that both LegH-c and LegH-d are mixtures of at least two heme proteins.
  35. [35]
    MtCAS31 Aids Symbiotic Nitrogen Fixation by Protecting ... - Frontiers
    May 13, 2018 · In this study, we found that the dehydrin MtCAS31 (cold-acclimation-specific 31) functions in SNF in Medicago truncatula during drought stress.
  36. [36]
    Symbiotic Leghemoglobins Are Crucial for Nitrogen Fixation in ...
    Report. Symbiotic Leghemoglobins Are Crucial for Nitrogen Fixation in Legume Root Nodules but Not for General Plant Growth and Development.
  37. [37]
    LEGHEMOGLOBIN AND RHIZOBIUM RESPIRATION
    LEGHEMOGLOBIN FUNCTION. 457. LEGHEMOGLOBIN AND RHIZOBIUM RESPIRATION. EFFICIENCY. Oxygen Delivery and Other Possible Leghemoglobin Functions. The demonstration ...
  38. [38]
    (PDF) Facilitated oxygen diffusion. The role of leghemoglobin in ...
    Sep 19, 2025 · The role of leghemoglobin in nitrogen fixation by bacteroids isolated from soybean root nodules. July 1974; Journal of Biological Chemistry ...
  39. [39]
    CRISPR/Cas9 knockout of leghemoglobin genes in Lotus japonicus ...
    Jul 29, 2019 · CRISPR/Cas9 knockout of leghemoglobin genes in Lotus japonicus uncovers their synergistic roles in symbiotic nitrogen fixation.
  40. [40]
    Legume Haemoglobins: Symbiotic Nitrogen Fixation Needs Bloody ...
    This is due to the high levels of haemoglobins, referred to as leghaemoglobins because they are always found in legume nodules [1]. As they report in this issue ...
  41. [41]
    Leghemoglobin green derivatives with nitrated hemes evidence ...
    In plants, the most abundant Hbs are the symbiotic leghemoglobins (Lbs) that scavenge O2 and facilitate its diffusion to the N2-fixing bacteroids in nodules.
  42. [42]
    Two Types of Pea Leghemoglobin Genes Showing Different O2 ...
    The number of detectable isoleghemoglobins (isoLbs) varies among legume species: eight in soybean (Glycine max; Fuchsman and Appleby, 1979), five in pea (Pisum ...Missing: variations across
  43. [43]
    Identification of two groups of leghemoglobin genes in alfalfa ...
    ... situation in soybean and suggests that important differences in leghemoglobin gene regulation exist between these two distantly related legume species.Missing: variations across
  44. [44]
    Leghemoglobin variability in the genus Phaseolus
    Interspecific hybrids were produced to transfer existing leghemoglobin variability into the P. vulgaris background. Leghemoglobins were also shown to be ...
  45. [45]
    Genetics and Genomics of Symbiotic Nitrogen Fixation in Legumes
    Mar 4, 2025 · Leghemoglobins are the most abundant plant proteins in nodules, and the corresponding gene families in legumes have expanded relative to those ...
  46. [46]
    Non-symbiotic haemoglobins—What's happening beyond nitric ...
    Non-symbiotic haemoglobins have been found to function in seed development and germination, flowering, root development and differentiation, abiotic stress ...
  47. [47]
    Structural and functional properties of class 1 plant hemoglobins
    Nonsymbiotic class 1 plant hemoglobins are induced under hypoxia. Structurally they are protein dimers consisting of two identical subunits, each containing ...
  48. [48]
    Crystal structure of a nonsymbiotic plant hemoglobin - ScienceDirect
    Background: Nonsymbiotic hemoglobins (nsHbs) form a new class of plant proteins that is distinct genetically and structurally from leghemoglobins.
  49. [49]
    Structural Insights into the Heme Pocket and Oligomeric State of ...
    In comparison, AHb2 possesses lower oxygen affinity (Kd ≈ 100–200 nM), low rates of oxygen binding (~1 µM−1 s−1), relatively low dissociation rate constants for ...
  50. [50]
    Non-symbiotic hemoglobin and its relation with hypoxic stress
    In 1939 Kubo was the first to describe a plant hemoglobin, from the Rhizobium nodules in roots of a soybean plant (Kubo, 1939). The isolation of hemoglobin ...
  51. [51]
    Nonsymbiotic Hemoglobin-2 Leads to an Elevated Energy State and ...
    Nonsymbiotic hemoglobins are widely distributed in plants and divided into two different classes based on gene expression pattern and oxygen-binding properties.
  52. [52]
    The structure and function of plant hemoglobins - ScienceDirect.com
    SHbs were first discovered by Kubo in 1939. These proteins are found in millimolar quantities in the nodules that form on the roots of plants in symbiosis ...Missing: early | Show results with:early
  53. [53]
    Structural analysis in nonsymbiotic hemoglobins: What can we learn ...
    Plants contain three classes of hemoglobins which are not associated with nitrogen fixing bacteria, and have been accordingly termed nonsymbiotic ...
  54. [54]
    Overexpression of spinach non-symbiotic hemoglobin in ... - Nature
    May 23, 2016 · A class 1 non-symbiotic hemoglobin family gene, SoHb, was isolated from spinach. qRT-PCR showed that SoHb was induced by excess nitrate, ...
  55. [55]
    Expression of the Tobacco Non-symbiotic Class 1 Hemoglobin ...
    Hemoglobin (Hb) proteins are ubiquitous in plants, and non-symbiotic class 1 hemoglobin (Hb1) is involved in various biotic and abiotic stress responses.Abstract · Introduction · Results · Discussion
  56. [56]
    Review Nonsymbiotic hemoglobins and stress tolerance in plants
    This review describes the function of plant hemoglobins with particular emphasis on nonsymbiotic hemoglobins and their role in stress tolerance in plants. The ...<|control11|><|separator|>
  57. [57]
    4C0N: Crystal structure of non symbiotic plant hemoglobin AHb3 ...
    May 14, 2014 · Plant nonsymbiotic haemoglobins fall into three classes, each with distinct properties but all with largely unresolved physiological functions.
  58. [58]
    Redox control and autoxidation of class 1, 2 and 3 phytoglobins from ...
    Sep 12, 2018 · The present study presents data on three recombinant Arabidopsis phytoglobins in terms of their UV-vis and Raman spectroscopic characteristics, redox state ...
  59. [59]
    Structure, Function, and Bioinformatics | Protein Science Journal
    Jan 23, 2008 · Nonsymbiotic hemoglobins (nsHbs) and leghemoglobins (Lbs) are plant proteins that can reversibly bind O2 and other ligands.<|separator|>
  60. [60]
    Assessment of soy leghemoglobin produced from genetically ...
    Nov 15, 2024 · Genetically modified Komagataella phaffii strain MXY0541 was developed to produce soy leghemoglobin by introducing the LGB2 coding sequence ...
  61. [61]
    High-level secretory production of leghemoglobin in Pichia pastoris ...
    Sep 5, 2022 · A combination of inducible expression and constitutive expression resulted in the highest production of leghemoglobin.
  62. [62]
    High-level secretory production of leghemoglobin in Pichia pastoris ...
    A Pichia pastoris strain capable of high-yield secretory production of functional leghemoglobin was developed through gene dosage optimization and heme pathway ...
  63. [63]
    Pichia pastoris growth—coupled heme biosynthesis analysis using ...
    Sep 22, 2023 · To improve the high-yield production of leghemoglobin protein and its main component—heme in the yeast Pichia pastoris, glycerol and methanol ...Downregulation/deletions... · Genome-Scale Metabolic Model · Growth-Coupled Analysis
  64. [64]
    Efficient Secretory Expression of Leghemoglobin in Saccharomyces ...
    Mar 3, 2024 · The secretory expression of LegH was achieved in recombinant S. cerevisiae, and the final secretory titer of LegH reached 88.5 mg/L at the 5-L fermenter level.
  65. [65]
    High-level expression of leghemoglobin in Kluyveromyces ...
    Jan 8, 2024 · Enhancing cellular heme synthesis improves the recombinant expression of leghemoglobin in yeast. To achieve high-level expression of
  66. [66]
    Production and Purification of Soy Leghemoglobin from Pichia ...
    Nov 12, 2023 · In this study, we explored the expression of recombinant LegH in Pichia pastoris in various reported cultivation media (BSM, BMGY, FM22, D'Anjou, BSM/2, and ...2. Materials And Methods · 3. Results · 3.2. Cultivation Experiments
  67. [67]
    How do you make heme? - Impossible Foods
    Heme is made by fermenting genetically engineered yeast with soy leghemoglobin, then filtering and concentrating the heme.
  68. [68]
    Soy leghemoglobin (LegH) preparation as an ingredient in a ...
    May 4, 2021 · The manufacturing process of the LegH preparation consists of a controlled fermentation of the production organism which results in the ...Backgound · Introduction · Development of the Production... · Nutrition
  69. [69]
    The Safety of Soy Leghemoglobin Protein Preparation Derived ... - NIH
    Oct 10, 2023 · LegH Prep from P. pastoris has been used in the meat analog products produced by Impossible Foods since 2016 and has been sold and consumed ...
  70. [70]
    [PDF] Application A1186 Soy leghemoglobin in meat analogue products
    Dec 15, 2020 · The production of soy leghemoglobin is achieved through the expression of a leghemoglobin gene from soybean (Glycine max) as well as ...<|control11|><|separator|>
  71. [71]
    “Barebones” FDA review of Impossible Burger's soy leghemoglobin ...
    Sep 3, 2019 · Impossible Food told FDA: “Once cooked and digested, both soy leghemoglobin and animal-based myoglobin release identical heme B molecules into ...
  72. [72]
    Soy Leghemoglobin for Meaty Vegan Burgers - Soy Connection
    Impossible Foods transferred the soy LegH gene into yeast in order to produce large quantities of LegH protein as sustainably as possible. Production of this ...
  73. [73]
    Safety Evaluation of Soy Leghemoglobin Protein Preparation ...
    Replacing the myoglobin that catalyzes the unique flavor chemistry of meat derived from animals with LegH from soy opens an opportunity to develop plant-based ...Missing: alternatives | Show results with:alternatives
  74. [74]
    What is soy leghemoglobin, or heme? - Impossible Foods
    Soy leghemoglobin is a protein in soy that carries heme, an iron-containing molecule essential for life. Heme is found in all living beings.
  75. [75]
    Soy Leghemoglobin: A review of its structure, production, safety ...
    This indicates that the Pichia proteins can be incorporated into the plant-based meat product at a very low concentration (0.8%) without compromising the safety ...
  76. [76]
    FDA In Brief: FDA approves soy leghemoglobin as a color additive
    Jul 31, 2019 · The FDA has approved Impossible Foods' color additive petition for the use of soy leghemoglobin in alternative, non-animal protein sources, like vegetable ...
  77. [77]
    GRN No. 737 - GRAS Notices - FDA
    Intended Use: For use at levels up to 0.8% soybean leghemoglobin protein to optimize flavor in ground beef analogue products intended to be cooked.
  78. [78]
    Impossible Foods Receives Approval for Its Color Additive Petition ...
    Jul 30, 2019 · The FDA approved Impossible Foods' color additive petition, allowing the use of heme, a key ingredient, in future plant-based foods. This is ...
  79. [79]
    FDA Announces Effective Date for Final Rule Adding Soy ...
    Dec 17, 2019 · ... Impossible Foods, Inc. requesting FDA to issue a regulation listing the use of soy leghemoglobin as a color additive in food. This final ...
  80. [80]
    Appeals Court Ruling Allows Novel Genetically Engineered Soy ...
    May 3, 2021 · Today's ruling cements FDA's food additive approval, allowing Impossible Foods and other plant-based meat companies to use GE heme for no other ...
  81. [81]
    Heme-Burgers and Hot Dogs: Ninth Circuit Affirms FDA's Approval of ...
    May 19, 2021 · A US Court of Appeals for the Ninth Circuit panel recently affirmed a decision by the US Food and Drug Administration (FDA) approving soy leghemoglobin (also ...
  82. [82]
    [PDF] Application A1186 Soy leghemoglobin in meat analogue products
    Dec 15, 2020 · The applicant indicated that soy leghemoglobin was respectively permitted in Hong Kong and. Macau following approvals in the US and Singapore.
  83. [83]
    EU GMO Panel Says Impossible Burger 'Safe for Consumption'
    Nov 18, 2024 · Impossible Foods has received a positive safety assessment by the EU for its genetically modified heme ingredient.
  84. [84]
    Assessment of soy leghemoglobin produced from genetically ...
    Feb 24, 2025 · The Norwegian Scientific Committee for Food and Environment (VKM) has assessed an application for approval of soy leghemoglobin produced from ...
  85. [85]
    Soy Leghemoglobin Market Size and Share Forecast Outlook 2025 ...
    North America currently has the highest adoption rate in the global soy leghemoglobin market ... The Impossible™ Burger has been introduced into the Canadian ...
  86. [86]
    Asia-Pacific Soy Leghemoglobin Market: Fastest Growth
    Oct 6, 2025 · The global soy leghemoglobin market is projected to increase from USD 311.0 billion in 2025 to USD 844.1 billion by 2035, with a Compound ...
  87. [87]
    Safety evaluation of soy leghemoglobin protein preparation derived ...
    Oct 1, 2017 · Systemic and female reproductive toxicity were assessed in two separate 28-day dietary studies in Sprague Dawley rats. There were no mortalities ...
  88. [88]
    [PDF] 4- rffll US FOOD & DRUG - FDA
    Mar 7, 2025 · IFI states that soy leghemoglobin preparation is non-mutagenic and non-clastogenic. Potential allergenicity of proteins in the soy leghemoglobin ...
  89. [89]
    Evaluating Potential Risks of Food Allergy and Toxicity of Soy ...
    6 They share an identical heme cofactor (heme B), which binds oxygen with high affinity. These mammalian myoglobins share a common history of safe use in ...
  90. [90]
    [PDF] 1 Date: June 21, 2019 From: Supratim Choudhuri, Ph.D., Toxicology ...
    Soy leghemoglobin and the P. pastoris proteins are nontoxigenic and nonpathogenic proteins with well-defined physiological functions. Addressing the ...<|separator|>
  91. [91]
    Assessment of the potential allergenicity and toxicity of Pichia ...
    Overall, results of these studies have shown no issues of toxicological concern with regard to LegH Prep under the conditions tested (Fraser et al., 2018).
  92. [92]
    Listing of Color Additives Exempt From Certification - Regulations.gov
    Aug 1, 2019 · ... soy leghemoglobin preparation is GRAS for its intended conditions of use. Importantly, in our response letter to Impossible Foods, we stated ...
  93. [93]
    Blog | | 5 Myths Impossible Burger is Serving Up
    Oct 28, 2019 · TRUTH: FDA has not acknowledged that soy leghemoglobin is safe to eat "multiple times." Impossible Foods chose to go through a legal loophole to ...Missing: criticisms | Show results with:criticisms<|control11|><|separator|>
  94. [94]
    Plant‐Based Analogs: Potential Chemical Risks & Mitigation ...
    Sep 21, 2025 · For example, a 28-day dietary study of heme (leghemoglobin protein) in rats confirmed no toxicological risks (Fraser et al. 2018). However, the ...
  95. [95]
    Soy Leghemoglobin: A review of its structure, production, safety ...
    It further highlights critical research gaps, including the need to identify potential chemical toxicants in plant‐based analogs and to elucidate the long‐term ...Missing: empirical | Show results with:empirical
  96. [96]
    [PDF] 1 Comments on EFSA opinions on Impossible Foods' application for ...
    Dec 13, 2024 · Soy leghemoglobin is red in colour and has a meat-like flavour. Impossible Foods uses GM yeast-derived soy leghemoglobin in its meat substitute ...
  97. [97]
    High-level expression of leghemoglobin in Kluyveromyces ...
    Jan 7, 2024 · Leghemoglobin was discovered in Glycine max in 1939 (Hoy and Hargrove, 2008). It is synthesized collaboratively by symbiotic rhizobia bacteria ...
  98. [98]
    (PDF) Production and Purification of Soy Leghemoglobin from ...
    Oct 12, 2025 · In this study, we explored the expression of recombinant LegH in Pichia pastoris in various reported cultivation media (BSM, BMGY, FM22, D'Anjou ...<|separator|>
  99. [99]
    Cell-Free Production of Soybean Leghemoglobins and ...
    Aug 12, 2025 · Despite being discovered over 70 years ago, (6) LegH has recently garnered significant attention for potential use as a food additive in ...
  100. [100]
  101. [101]
    Engineered Leghemoglobin as a High-Performance Biocatalyst for ...
    Leghemoglobin (LegH), a plant-derived hemoprotein, is engineered for the first time as a standalone biocatalyst for carbene N–H insertion.
  102. [102]
  103. [103]
    Metabolic engineering of Bacillus subtilis for the production of active ...
    The large-scale biosynthesis of active hemoproteins for applications in the manufacture of food and medicine remains a significant challenge.Abstract · Sign Up For Pnas Alerts · Results<|control11|><|separator|>